Grow Therapy
Supports providers delivering in-person and online therapy and psychiatric care.
$150MSeries D
Role not disclosedT
TCV
Activity from announced rounds
Activity in this selectionMar 31, 2026 · AI · Mar 1, 2026
TCV is a global technology growth-equity investor, with equity investments ranging from $10 million to $500 million and flexibility around transaction structure.
Its approach is to maintain a concentrated portfolio and commit substantial time and capital to a selected group of companies. It remains involved as businesses expand their products and enter additional geographies.
The firm’s offices in Menlo Park, New York and London support a portfolio spanning five continents. Its financing model is suited to growth-stage technology businesses undertaking a significant expansion rather than only the first product-development round.
Sources
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $150M 1 disclosed · full round size, not this investor’s share